Prostap and retained products of conception Patient Reports February 11, 2012

Prostap Side Effects Report #5242188-9
Prostap side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 07, 2007. Female patient, 35 years of age, was diagnosed with in vitro fertilisation and was treated with Prostap. After drug was administered, patient experienced the following side effects: abortion induced, pregnancy , retained products of conception. Prostap dosage: 3.75 MG (3.75 MG, 1 IN 1 M);. During the same period patient was treated with PUREGON, PREGNYL, RAPIFEN, DIPRIVAN, IN VITRO FERTILISATION, CYCLOGEST PESSARIES. Patient recovered.